25 XP   0   0   10

Zhejiang Orient Gene Biotech Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Orient Gene Biotech Co Ltd together

PenkeI guess you are interested in Zhejiang Orient Gene Biotech Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Orient Gene Biotech Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Orient Gene Biotech Co Ltd

I send you an email if I find something interesting about Zhejiang Orient Gene Biotech Co Ltd.

Quick analysis of Zhejiang Orient Gene Biotech Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Orient Gene Biotech Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥2.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥41.28
Expected worth in 1 year
¥69.74
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥43.18
Return On Investment
158.5%

For what price can you sell your share?

Current Price per Share
¥27.25
Expected price per share
¥25.00 - ¥31.25
How sure are you?
50%

1. Valuation of Zhejiang Orient Gene Biotech Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥27.25

Intrinsic Value Per Share

¥131.67 - ¥258.10

Total Value Per Share

¥172.95 - ¥299.38

2. Growth of Zhejiang Orient Gene Biotech Co Ltd (5 min.)




Is Zhejiang Orient Gene Biotech Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$950.6m$197.9m17.2%

How much money is Zhejiang Orient Gene Biotech Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$285.3m$678.9m-$393.6m-138.0%
Net Profit Margin23.6%48.4%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Orient Gene Biotech Co Ltd (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#32 / 334

Most Revenue
#17 / 334

Most Profit
#13 / 334

What can you expect buying and holding a share of Zhejiang Orient Gene Biotech Co Ltd? (5 min.)

Welcome investor! Zhejiang Orient Gene Biotech Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Orient Gene Biotech Co Ltd.

What can you expect buying and holding a share of Zhejiang Orient Gene Biotech Co Ltd?

First you should know what it really means to hold a share of Zhejiang Orient Gene Biotech Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Orient Gene Biotech Co Ltd is ¥27.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Orient Gene Biotech Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Orient Gene Biotech Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥41.28. Based on the TTM, the Book Value Change Per Share is ¥7.11 per quarter. Based on the YOY, the Book Value Change Per Share is ¥22.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥3.68 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Orient Gene Biotech Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps1.425.2%1.425.2%3.3712.4%1.214.4%0.873.2%
Usd Book Value Change Per Share0.983.6%0.983.6%3.0411.1%1.124.1%0.813.0%
Usd Dividend Per Share0.511.9%0.511.9%0.351.3%0.180.7%0.130.5%
Usd Total Gains Per Share1.495.5%1.495.5%3.3812.4%1.304.8%0.943.5%
Usd Price Per Share10.64-10.64-31.81-14.09-10.07-
Price to Earnings Ratio7.52-7.52-9.44-8.27-5.91-
Price-to-Total Gains Ratio7.14-7.14-9.40-11.65-11.65-
Price to Book Ratio1.87-1.87-6.75-5.06-3.62-
Price-to-Total Gains Ratio7.14-7.14-9.40-11.65-11.65-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.7605
Number of shares265
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.510.18
Usd Book Value Change Per Share0.981.12
Usd Total Gains Per Share1.491.30
Gains per Quarter (265 shares)394.77344.43
Gains per Year (265 shares)1,579.071,377.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15381041156919011881368
210772081314838023762746
316153122472757035634124
421544163630676047515502
526925203788595059396880
6323162449464114071278258
73769728511043133083149636
843078325126221520950211014
9484693661420117101069012392
105384104071578018991187813770

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%

Fundamentals of Zhejiang Orient Gene Biotech Co Ltd

About Zhejiang Orient Gene Biotech Co Ltd

Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells in vitro diagnostic products worldwide. The company offers IFA solutions, digital test, oral fluid test, and covid-19 test products; and immunological diagnosis product, such as hair drug test kit, monkeypox, saliva drug test, urine multi-drug test, urine single-drug test, rapid test, digital pregnancy test, male-fertility test, menopause test, and other test products. It also provides molecular diagnosis products, including nucleic acid extraction systems, real time PCR systems, virus detection kits, viral nucleic acid extraction kits, and general products; liquid biochip products; mini immunofluorescence analyzers, handheld fluorescence immunoassay analyzers, fluorescence immunoassay analyzers, handheld oral fluid drug test readers, colloidal gold test readers, and urine drug test cup readers; and dry biochemical strips comprising urine reagent strips, urine analyzers, alcohol test, and vaginal pH test products. In addition, the company offers raw materials for fertility, tumor and cardiac marker, drugs of abuse, infectious diseases, pet, antibody, and others; and FISH probes comprising solid tumor probes, chromosome test, hematologic disease probes, reagents, and instruments. Zhejiang Orient Gene Biotech Co., Ltd. was founded in 2005 and is based in Huzhou, China.

Fundamental data was last updated by Penke on 2024-04-18 18:12:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Zhejiang Orient Gene Biotech Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Orient Gene Biotech Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Orient Gene Biotech Co Ltd to the Medical Devices industry mean.
  • A Net Profit Margin of 23.6% means that ¥0.24 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Orient Gene Biotech Co Ltd:

  • The MRQ is 23.6%. The company is making a huge profit. +2
  • The TTM is 23.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ23.6%TTM23.6%0.0%
TTM23.6%YOY48.4%-24.8%
TTM23.6%5Y33.7%-10.1%
5Y33.7%10Y29.0%+4.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ23.6%-12.4%+36.0%
TTM23.6%-20.4%+44.0%
YOY48.4%-14.4%+62.8%
5Y33.7%-21.3%+55.0%
10Y29.0%-25.0%+54.0%
1.1.2. Return on Assets

Shows how efficient Zhejiang Orient Gene Biotech Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Orient Gene Biotech Co Ltd to the Medical Devices industry mean.
  • 19.3% Return on Assets means that Zhejiang Orient Gene Biotech Co Ltd generated ¥0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Orient Gene Biotech Co Ltd:

  • The MRQ is 19.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 19.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ19.3%TTM19.3%0.0%
TTM19.3%YOY54.8%-35.5%
TTM19.3%5Y32.6%-13.3%
5Y32.6%10Y27.3%+5.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ19.3%-4.1%+23.4%
TTM19.3%-4.7%+24.0%
YOY54.8%-4.6%+59.4%
5Y32.6%-4.0%+36.6%
10Y27.3%-5.2%+32.5%
1.1.3. Return on Equity

Shows how efficient Zhejiang Orient Gene Biotech Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Orient Gene Biotech Co Ltd to the Medical Devices industry mean.
  • 25.3% Return on Equity means Zhejiang Orient Gene Biotech Co Ltd generated ¥0.25 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Orient Gene Biotech Co Ltd:

  • The MRQ is 25.3%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 25.3%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ25.3%TTM25.3%0.0%
TTM25.3%YOY71.8%-46.4%
TTM25.3%5Y46.2%-20.8%
5Y46.2%10Y41.7%+4.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ25.3%-4.2%+29.5%
TTM25.3%-5.8%+31.1%
YOY71.8%-5.5%+77.3%
5Y46.2%-6.3%+52.5%
10Y41.7%-7.1%+48.8%

1.2. Operating Efficiency of Zhejiang Orient Gene Biotech Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Orient Gene Biotech Co Ltd is operating .

  • Measures how much profit Zhejiang Orient Gene Biotech Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Orient Gene Biotech Co Ltd to the Medical Devices industry mean.
  • An Operating Margin of 25.8% means the company generated ¥0.26  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Orient Gene Biotech Co Ltd:

  • The MRQ is 25.8%. The company is operating very efficient. +2
  • The TTM is 25.8%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ25.8%TTM25.8%0.0%
TTM25.8%YOY57.8%-32.1%
TTM25.8%5Y38.5%-12.7%
5Y38.5%10Y34.3%+4.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ25.8%-24.3%+50.1%
TTM25.8%-16.4%+42.2%
YOY57.8%-14.0%+71.8%
5Y38.5%-20.4%+58.9%
10Y34.3%-24.8%+59.1%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Orient Gene Biotech Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.14 means that the operating costs are ¥1.14 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Orient Gene Biotech Co Ltd:

  • The MRQ is 1.136. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.136. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.136TTM1.1360.000
TTM1.136YOY0.684+0.452
TTM1.1365Y0.980+0.156
5Y0.98010Y1.066-0.086
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1361.456-0.320
TTM1.1361.439-0.303
YOY0.6841.431-0.747
5Y0.9801.436-0.456
10Y1.0661.374-0.308

1.3. Liquidity of Zhejiang Orient Gene Biotech Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Orient Gene Biotech Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.84 means the company has ¥3.84 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Orient Gene Biotech Co Ltd:

  • The MRQ is 3.839. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.839. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.839TTM3.8390.000
TTM3.839YOY3.948-0.109
TTM3.8395Y3.123+0.716
5Y3.12310Y2.627+0.496
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8392.693+1.146
TTM3.8392.697+1.142
YOY3.9483.504+0.444
5Y3.1233.617-0.494
10Y2.6273.499-0.872
1.3.2. Quick Ratio

Measures if Zhejiang Orient Gene Biotech Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Orient Gene Biotech Co Ltd to the Medical Devices industry mean.
  • A Quick Ratio of 0.65 means the company can pay off ¥0.65 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Orient Gene Biotech Co Ltd:

  • The MRQ is 0.645. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.645. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.645TTM0.6450.000
TTM0.645YOY0.657-0.012
TTM0.6455Y0.702-0.057
5Y0.70210Y0.604+0.098
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6451.516-0.871
TTM0.6451.658-1.013
YOY0.6572.142-1.485
5Y0.7022.307-1.605
10Y0.6042.370-1.766

1.4. Solvency of Zhejiang Orient Gene Biotech Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Orient Gene Biotech Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Orient Gene Biotech Co Ltd to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.22 means that Zhejiang Orient Gene Biotech Co Ltd assets are financed with 22.2% credit (debt) and the remaining percentage (100% - 22.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Orient Gene Biotech Co Ltd:

  • The MRQ is 0.222. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.222. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.222TTM0.2220.000
TTM0.222YOY0.233-0.010
TTM0.2225Y0.290-0.068
5Y0.29010Y0.358-0.068
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2220.402-0.180
TTM0.2220.389-0.167
YOY0.2330.335-0.102
5Y0.2900.442-0.152
10Y0.3580.461-0.103
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Orient Gene Biotech Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Orient Gene Biotech Co Ltd to the Medical Devices industry mean.
  • A Debt to Equity ratio of 29.2% means that company has ¥0.29 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Orient Gene Biotech Co Ltd:

  • The MRQ is 0.292. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.292. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.292TTM0.2920.000
TTM0.292YOY0.305-0.013
TTM0.2925Y0.425-0.134
5Y0.42510Y0.639-0.214
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2920.559-0.267
TTM0.2920.560-0.268
YOY0.3050.479-0.174
5Y0.4250.614-0.189
10Y0.6390.674-0.035

2. Market Valuation of Zhejiang Orient Gene Biotech Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Orient Gene Biotech Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Orient Gene Biotech Co Ltd to the Medical Devices industry mean.
  • A PE ratio of 7.52 means the investor is paying ¥7.52 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Orient Gene Biotech Co Ltd:

  • The EOD is 2.657. Based on the earnings, the company is cheap. +2
  • The MRQ is 7.518. Based on the earnings, the company is underpriced. +1
  • The TTM is 7.518. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.657MRQ7.518-4.861
MRQ7.518TTM7.5180.000
TTM7.518YOY9.445-1.926
TTM7.5185Y8.272-0.754
5Y8.27210Y5.909+2.363
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.657-1.021+3.678
MRQ7.518-1.704+9.222
TTM7.518-2.081+9.599
YOY9.445-2.980+12.425
5Y8.272-2.379+10.651
10Y5.909-1.726+7.635
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Orient Gene Biotech Co Ltd:

  • The EOD is 2.826. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.997. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 7.997. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD2.826MRQ7.997-5.171
MRQ7.997TTM7.9970.000
TTM7.997YOY9.895-1.899
TTM7.9975Y8.499-0.502
5Y8.49910Y6.071+2.428
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD2.826-0.981+3.807
MRQ7.997-1.578+9.575
TTM7.997-2.973+10.970
YOY9.895-6.179+16.074
5Y8.499-4.928+13.427
10Y6.071-5.060+11.131
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Orient Gene Biotech Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.87 means the investor is paying ¥1.87 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Orient Gene Biotech Co Ltd:

  • The EOD is 0.660. Based on the equity, the company is cheap. +2
  • The MRQ is 1.868. Based on the equity, the company is underpriced. +1
  • The TTM is 1.868. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.660MRQ1.868-1.208
MRQ1.868TTM1.8680.000
TTM1.868YOY6.746-4.878
TTM1.8685Y5.062-3.194
5Y5.06210Y3.615+1.446
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.6601.930-1.270
MRQ1.8682.372-0.504
TTM1.8682.444-0.576
YOY6.7463.205+3.541
5Y5.0623.893+1.169
10Y3.6154.245-0.630
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Orient Gene Biotech Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--7.1147.1140%22.011-68%8.120-12%5.898+21%
Book Value Per Share--41.28541.2850%34.171+21%17.982+130%13.012+217%
Current Ratio--3.8393.8390%3.948-3%3.123+23%2.627+46%
Debt To Asset Ratio--0.2220.2220%0.233-4%0.290-23%0.358-38%
Debt To Equity Ratio--0.2920.2920%0.305-4%0.425-31%0.639-54%
Dividend Per Share--3.6813.6810%2.503+47%1.299+183%0.935+294%
Eps--10.25710.2570%24.406-58%8.743+17%6.293+63%
Free Cash Flow Per Share--9.6439.6430%23.294-59%8.305+16%5.951+62%
Free Cash Flow To Equity Per Share--6.1796.1790%20.768-70%7.541-18%5.393+15%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--258.099--------
Intrinsic Value_10Y_min--131.668--------
Intrinsic Value_1Y_max--16.382--------
Intrinsic Value_1Y_min--9.635--------
Intrinsic Value_3Y_max--56.447--------
Intrinsic Value_3Y_min--32.204--------
Intrinsic Value_5Y_max--105.224--------
Intrinsic Value_5Y_min--58.165--------
Market Cap5493600000.000-183%15545376000.00015545376000.0000%46468820160.000-67%20587795200.000-24%14705568000.000+6%
Net Profit Margin--0.2360.2360%0.484-51%0.337-30%0.290-19%
Operating Margin--0.2580.2580%0.578-55%0.385-33%0.343-25%
Operating Ratio--1.1361.1360%0.684+66%0.980+16%1.066+7%
Pb Ratio0.660-183%1.8681.8680%6.746-72%5.062-63%3.615-48%
Pe Ratio2.657-183%7.5187.5180%9.445-20%8.272-9%5.909+27%
Price Per Share27.250-183%77.11077.1100%230.500-67%102.122-24%72.944+6%
Price To Free Cash Flow Ratio2.826-183%7.9977.9970%9.895-19%8.499-6%6.071+32%
Price To Total Gains Ratio2.524-183%7.1437.1430%9.403-24%11.653-39%11.653-39%
Quick Ratio--0.6450.6450%0.657-2%0.702-8%0.604+7%
Return On Assets--0.1930.1930%0.548-65%0.326-41%0.273-29%
Return On Equity--0.2530.2530%0.718-65%0.462-45%0.417-39%
Total Gains Per Share--10.79510.7950%24.514-56%9.418+15%6.833+58%
Usd Book Value--1148573210.5811148573210.5810%950652907.565+21%500259747.567+130%361997400.541+217%
Usd Book Value Change Per Share--0.9820.9820%3.037-68%1.121-12%0.814+21%
Usd Book Value Per Share--5.6975.6970%4.716+21%2.481+130%1.796+217%
Usd Dividend Per Share--0.5080.5080%0.345+47%0.179+183%0.129+294%
Usd Eps--1.4151.4150%3.368-58%1.207+17%0.868+63%
Usd Free Cash Flow--268270373.855268270373.8550%648045403.656-59%231042441.961+16%165568859.352+62%
Usd Free Cash Flow Per Share--1.3311.3310%3.215-59%1.146+16%0.821+62%
Usd Free Cash Flow To Equity Per Share--0.8530.8530%2.866-70%1.041-18%0.744+15%
Usd Market Cap758116800.000-183%2145261888.0002145261888.0000%6412697182.080-67%2841115737.600-24%2029368384.000+6%
Usd Price Per Share3.761-183%10.64110.6410%31.809-67%14.093-24%10.066+6%
Usd Profit--285344577.209285344577.2090%678985964.239-58%243231512.400+17%175096757.988+63%
Usd Revenue--1209975458.6791209975458.6790%1403345144.709-14%630818179.170+92%458598122.754+164%
Usd Total Gains Per Share--1.4901.4900%3.383-56%1.300+15%0.943+58%
 EOD+4 -4MRQTTM+0 -0YOY+11 -245Y+21 -1410Y+26 -9

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Orient Gene Biotech Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-152.657
Price to Book Ratio (EOD)Between0-10.660
Net Profit Margin (MRQ)Greater than00.236
Operating Margin (MRQ)Greater than00.258
Quick Ratio (MRQ)Greater than10.645
Current Ratio (MRQ)Greater than13.839
Debt to Asset Ratio (MRQ)Less than10.222
Debt to Equity Ratio (MRQ)Less than10.292
Return on Equity (MRQ)Greater than0.150.253
Return on Assets (MRQ)Greater than0.050.193
Total9/10 (90.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Orient Gene Biotech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.588
Ma 20Greater thanMa 5028.807
Ma 50Greater thanMa 10030.299
Ma 100Greater thanMa 20032.737
OpenGreater thanClose27.430
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets10,703,739
Total Liabilities2,380,745
Total Stockholder Equity8,162,846
 As reported
Total Liabilities 2,380,745
Total Stockholder Equity+ 8,162,846
Total Assets = 10,703,739

Assets

Total Assets10,703,739
Total Current Assets8,747,481
Long-term Assets1,956,258
Total Current Assets
Cash And Cash Equivalents 6,596,975
Short-term Investments 1,160,676
Net Receivables 309,357
Inventory 431,919
Other Current Assets 85,987
Total Current Assets  (as reported)8,747,481
Total Current Assets  (calculated)8,584,914
+/- 162,567
Long-term Assets
Property Plant Equipment 1,074,241
Intangible Assets 457,995
Other Assets 365,190
Long-term Assets  (as reported)1,956,258
Long-term Assets  (calculated)1,897,426
+/- 58,832

Liabilities & Shareholders' Equity

Total Current Liabilities2,278,481
Long-term Liabilities102,265
Total Stockholder Equity8,162,846
Total Current Liabilities
Short Long Term Debt 3,551
Accounts payable 1,580,069
Other Current Liabilities 476,054
Total Current Liabilities  (as reported)2,278,481
Total Current Liabilities  (calculated)2,059,674
+/- 218,807
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt28,645
Other Liabilities 23,619
Deferred Long Term Liability 36,324
Long-term Liabilities  (as reported)102,265
Long-term Liabilities  (calculated)88,589
+/- 13,676
Total Stockholder Equity
Common Stock168,000
Retained Earnings 7,530,257
Other Stockholders Equity 28,267
Total Stockholder Equity (as reported)8,162,846
Total Stockholder Equity (calculated)7,726,524
+/- 436,321
Other
Capital Stock168,000
Common Stock Shares Outstanding 168,000
Net Invested Capital 8,216,397
Net Tangible Assets 7,681,607
Net Working Capital 6,469,000
Property Plant and Equipment Gross 1,585,601



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
240,998
259,318
337,648
361,511
3,573,223
8,976,971
10,703,739
10,703,7398,976,9713,573,223361,511337,648259,318240,998
   > Total Current Assets 
168,851
179,733
243,718
259,687
3,319,339
8,126,424
8,747,481
8,747,4818,126,4243,319,339259,687243,718179,733168,851
       Cash And Cash Equivalents 
80,787
77,907
102,551
85,437
2,038,613
6,098,182
6,596,975
6,596,9756,098,1822,038,61385,437102,55177,90780,787
       Short-term Investments 
0
0
0
0
199,000
168,068
1,160,676
1,160,676168,068199,0000000
       Net Receivables 
41,029
49,012
62,531
87,133
625,820
1,184,430
309,357
309,3571,184,430625,82087,13362,53149,01241,029
       Inventory 
45,202
49,382
75,534
77,964
381,578
470,562
431,919
431,919470,562381,57877,96475,53449,38245,202
       Other Current Assets 
1,832
3,432
3,102
9,154
30,498
151,218
85,987
85,987151,21830,4989,1543,1023,4321,832
   > Long-term Assets 
72,147
79,585
93,929
101,824
253,884
850,547
1,956,258
1,956,258850,547253,884101,82493,92979,58572,147
       Property Plant Equipment 
29,103
31,347
48,185
77,880
162,391
481,337
1,074,241
1,074,241481,337162,39177,88048,18531,34729,103
       Goodwill 
0
0
0
0
0
15,414
0
015,41400000
       Intangible Assets 
10,428
9,993
276
373
14,135
111,477
457,995
457,995111,47714,1353732769,99310,428
       Other Assets 
32,617
38,245
35,919
9,329
77,358
216,865
365,190
365,190216,86577,3589,32935,91938,24532,617
> Total Liabilities 
142,281
121,201
129,618
107,385
1,121,810
2,088,182
2,380,745
2,380,7452,088,1821,121,810107,385129,618121,201142,281
   > Total Current Liabilities 
137,083
116,503
121,262
91,517
1,113,010
2,058,515
2,278,481
2,278,4812,058,5151,113,01091,517121,262116,503137,083
       Short Long Term Debt 
76,000
56,000
50,000
20,435
2,380
5,837
3,551
3,5515,8372,38020,43550,00056,00076,000
       Accounts payable 
39,768
47,016
48,603
49,152
371,974
1,173,678
1,580,069
1,580,0691,173,678371,97449,15248,60347,01639,768
       Other Current Liabilities 
14,375
6,181
14,098
8,511
643,392
751,052
476,054
476,054751,052643,3928,51114,0986,18114,375
   > Long-term Liabilities 
5,198
4,698
8,356
15,868
8,800
29,667
102,265
102,26529,6678,80015,8688,3564,6985,198
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
2,838
12,652
28,645
28,64512,6522,8380000
       Other Liabilities 
5,198
4,698
8,356
9,300
8,800
17,015
23,619
23,61917,0158,8009,3008,3564,6985,198
> Total Stockholder Equity
98,717
133,489
201,034
251,728
2,446,043
6,857,174
8,162,846
8,162,8466,857,1742,446,043251,728201,034133,48998,717
   Common Stock
86,528
90,000
90,000
90,000
120,000
120,000
168,000
168,000120,000120,00090,00090,00090,00086,528
   Retained Earnings Total Equity0000000
   Accumulated Other Comprehensive Income 0000000
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
-696
-502
810
899
-7,763
-12,723
28,267
28,267-12,723-7,763899810-502-696



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,562,351
Cost of Revenue-1,231,602
Gross Profit330,749330,749
 
Operating Income (+$)
Gross Profit330,749
Operating Expense-1,983,684
Operating Income-421,332-1,652,934
 
Operating Expense (+$)
Research Development299,465
Selling General Administrative296,759
Selling And Marketing Expenses-
Operating Expense1,983,684596,224
 
Net Interest Income (+$)
Interest Income41,796
Interest Expense-11,323
Other Finance Cost-285,238
Net Interest Income-254,766
 
Pretax Income (+$)
Operating Income-421,332
Net Interest Income-254,766
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,228,783-421,332
EBIT - interestExpense = -11,323
-1,056,204
-1,044,881
Interest Expense11,323
Earnings Before Interest and Taxes (EBIT)--1,217,460
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,228,783
Tax Provision--172,588
Net Income From Continuing Ops-1,056,195-1,056,195
Net Income-1,056,204
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-254,766
 

Technical Analysis of Zhejiang Orient Gene Biotech Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Orient Gene Biotech Co Ltd. The general trend of Zhejiang Orient Gene Biotech Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Orient Gene Biotech Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Orient Gene Biotech Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 28.70 < 29.37 < 31.25.

The bearish price targets are: 25.00.

Tweet this
Zhejiang Orient Gene Biotech Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Orient Gene Biotech Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Orient Gene Biotech Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Orient Gene Biotech Co Ltd. The current macd is -1.03458949.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Orient Gene Biotech Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zhejiang Orient Gene Biotech Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zhejiang Orient Gene Biotech Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Orient Gene Biotech Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Orient Gene Biotech Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Orient Gene Biotech Co Ltd. The current adx is 29.97.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zhejiang Orient Gene Biotech Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Zhejiang Orient Gene Biotech Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Orient Gene Biotech Co Ltd. The current sar is 27.65.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zhejiang Orient Gene Biotech Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Orient Gene Biotech Co Ltd. The current rsi is 36.59. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Zhejiang Orient Gene Biotech Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Orient Gene Biotech Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Orient Gene Biotech Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Orient Gene Biotech Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Orient Gene Biotech Co Ltd Daily Stochastic Oscillator ChartZhejiang Orient Gene Biotech Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Orient Gene Biotech Co Ltd. The current cci is -75.41564394.

Zhejiang Orient Gene Biotech Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Orient Gene Biotech Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Orient Gene Biotech Co Ltd. The current cmo is -29.00802957.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zhejiang Orient Gene Biotech Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Orient Gene Biotech Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Orient Gene Biotech Co Ltd. The current willr is -71.09704641.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Zhejiang Orient Gene Biotech Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Zhejiang Orient Gene Biotech Co Ltd Daily Williams %R ChartZhejiang Orient Gene Biotech Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Orient Gene Biotech Co Ltd.

Zhejiang Orient Gene Biotech Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Orient Gene Biotech Co Ltd. The current atr is 1.07719697.

Zhejiang Orient Gene Biotech Co Ltd Daily Average True Range (ATR) ChartZhejiang Orient Gene Biotech Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Orient Gene Biotech Co Ltd. The current obv is -74,824,696.

Zhejiang Orient Gene Biotech Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Orient Gene Biotech Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Orient Gene Biotech Co Ltd. The current mfi is 31.79.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zhejiang Orient Gene Biotech Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Orient Gene Biotech Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Orient Gene Biotech Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Zhejiang Orient Gene Biotech Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Orient Gene Biotech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.588
Ma 20Greater thanMa 5028.807
Ma 50Greater thanMa 10030.299
Ma 100Greater thanMa 20032.737
OpenGreater thanClose27.430
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Orient Gene Biotech Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Orient Gene Biotech Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Orient Gene Biotech Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Orient Gene Biotech Co Ltd

I send you an email if I find something interesting about Zhejiang Orient Gene Biotech Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Orient Gene Biotech Co Ltd.

Receive notifications about Zhejiang Orient Gene Biotech Co Ltd in your mailbox!